NCT00376714View on ClinicalTrials.gov

Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 16, 2006

Study Completion Date

April 3, 2007

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK233705

Trial Locations (5)

2060

GSK Investigational Site, Antwerp

3000

GSK Investigational Site, Leuven

4000

GSK Investigational Site, Liège

SE-413 45

GSK Investigational Site, Gothenburg

SE-221 85

GSK Investigational Site, Lund

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY